U.S. Markets closed

American Well Corporation (AMWL)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
17.14+0.25 (+1.48%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close16.89
Open16.84
Bid17.00 x 1400
Ask17.11 x 1800
Day's Range16.50 - 17.15
52 Week Range15.53 - 43.75
Volume2,282,051
Avg. Volume3,664,818
Market Cap4.081B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est26.67
  • 2 Contrarian Stocks to Buy That Are Down by More Than 50%
    Motley Fool

    2 Contrarian Stocks to Buy That Are Down by More Than 50%

    Amwell (NYSE: AMWL) and BlackBerry (NYSE: BB) have fallen hard of late. Both are down by more than 50% from their 52-week highs as investors have gravitated toward more value-oriented investments. Telehealth company Amwell (formerly known as American Well) went public in September, and while it started out strong, the stock has had a rough ride in recent weeks.

  • 3 Attractive Value Stocks to Buy in April
    Motley Fool

    3 Attractive Value Stocks to Buy in April

    At a time when the S&P 500 is trading at a whopping 40.3 price-to-earnings (P/E) ratio, it is safe to say that much of the juice has already been squeezed out of top-tier growth stocks. Today, let's look at why the telemedicine company, gold miner, and online flower vendor are the top value stocks to buy this month. Amwell is a telehealth provider with a market cap of just $4.2 billion.

  • Teladoc Shareholders Worried About Post-Pandemic Blues, But It's Amwell That's Seeing the Slowdown
    Motley Fool

    Teladoc Shareholders Worried About Post-Pandemic Blues, But It's Amwell That's Seeing the Slowdown

    Telemedicine pioneer Teladoc Health (NYSE: TDOC) had an incredible 2020. The pandemic turned the small but growing remote virtual care niche of the healthcare industry into a basic staple. Helped by its transformational acquisition of Livongo Health last autumn, Teladoc has dispelled those fears with an outlook for revenue to nearly double again in 2021.